Abstract
Colon tumor cells, unlike normal human fibroblasts, exhibited an uncoupling of low density lipoprotein (LDL)-derived cholesterol from cellular growth, when endogenous cholesterol synthesis was inhibited by mevinolin, a hydroxymethylglutaryl-CoA reductase (HMG-CoAR) competitive inhibitor [Fabricant, M., and Broitman, S.A. (1990)Cancer Res. 50, 632–636]. Further evaluation of cholesterol metabolism was conducted in two undifferentiated (SW480, SW1417) and two differentiated (HT29, CACO2) colonic adenocarcinoma (adeno-CA) cell lines and an untransformed human fibroblast, AG1519A. Cells grown in monolayer culture to near subconfluency were used to assess endogenous cholesterol synthesis by14C-acetate incorporation, in response to the following treatments in lipoprotein-deficient serum (LPDS)-supplemented minimum essential medium (MEM): LPDS alone, LDL, mevinolin, mevinolin with LDL, and 25-hydroxy-cholesterol (25-OH-CH). Complete fetal bovine serum (FBS)-supplemented MEM was used as control. All colon tumor lines exhibited similarly high endogenous cholesterol synthesis in both FBS and LPDS relative to the fibroblasts which demonstrated low basal levels in FBS and maximal synthesis in LPDS. LDL treatment did not inhibit cholesterol synthesis in colon tumor cells, but suppressed that in the fibroblast by 70%. Sterol repression of cholesterol synthesis mediated by 25-OH-CH occurred in all cells. Mevinolin caused a reduction in cholesterol synthesis in the colonic cancer cell lines, which was not further decreased by concurrent addition of LDL. In contrast, in mevinolin-treated fibroblasts, LDL further inhibited cholesterol synthesis. When the effect of cell density on cholesterol synthesis regulation was evaluated under conditions of sparse density in SW480 and SW1417, results indicated that (i) basal rates of cholesterol synthesis were higher, (ii) LDL inhibited cholesterol synthesis more effectively, and (iii) mevinolin or 25-OH-CH had a more pronounced effect than in subconfluent cells. Evaluation of LDL receptor activity through125I-LDL binding and internalization studies demonstrated LDL receptor expression was reduced by 37% in normal density cells relative to the low density cultures. In contrast to cholesterol synthesis, exogenous LDL could inhibit LDL receptor activity at both densities. Thus subconfluent growing colonic adenoCA cell lines retain the capacity for sterol repression, but, in contrast to normal fibroblasts, exhibit a high endogenous cholesterol synthesis which LDL cannot regulate.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- ACAT:
-
acyl cholesterol acyl transferase
- adeno-CA:
-
adeno-carcinoma
- ANOVA:
-
analysis of variance
- BSA:
-
bovine serum albumin
- FBS:
-
fetal bovine serum
- HMG0-CoAR:
-
3-hydroxy-3-methylglutaryl-CoA reductase
- 25-OH-CH:
-
25-hydro-cholesterol
- LDL:
-
low density lipoprotein (quantities refer to measured or derived protein)
- LDLR:
-
LDL receptor
- LPDS:
-
lipoprotein-deficient serum
- MEM:
-
minimum essential medium
- PBS:
-
phosphate-buffered saline
- TBS:
-
tris-buffered
References
Chen, H.W. (1984) Role of Cholesterol Metabolism in Cell Growth,Fed. Proc. 43(1), 126–130.
Brown, M.S., and Goldstein, J.L. (1986) A Receptor-Mediated Pathway for Cholesterol Homeostasis,Science 232(4756), 34–47.
Siperstein, M.D., Gyde, A.M., and Morris, H.P. (1971) Loss of Feedback Control of Hydroxymethylglutaryl Coenzyme A Reductase in Hepatomas,Proc. Natl. Acad. Sci. USA 68(2), 315–317.
Betteridge, D.J., Krone, W., Ford, W., Ford, J.M., and Morris, H.P. (1979) Regulation of Sterol Synthesis in Leukaemic Blast Cells: A Defect Resembling Familial Hypercholesterolaemia,Eur. J. Clin. Invest. 9(6), 439–441.
Clayman, R.V., Bilhartz, L.E., Buja, L.M., Spady, D.K., and Dietschy, J.M. (1986) Renal Cell Carcinoma in the Wistar-Lewis rat: A Model for Studying the Mechanisms of Cholesterol Acquisition by a Tumorin vivo, Cancer Res. 46(6), 2958–2963.
Vitols, S., Peterson, C., Larsson, O., Holm, P., and Aberg, B. (1992) Elevated Uptake of Low Density Lipoproteins by Human Lung Cancer Tissuein vivo, Cancer Res. 52(22), 6244–6247.
Norata, G., Canti, G., Ricci, L., Nicolin, A., Trezzi, E., and Catapano, A.L. (1984)In vivo Assimilation of Low Density Lipoproteins by a Fibrosarcoma Tumour Line in Mice,Cancer Lett. 25(2), 203–208.
Hynds, S.A., Welsh, J., Stewart, J.M., Jack, A., Soukop, M., McArdle, C.S., Calman, K.C., Packard, C.J., and Shepherd, J. (1984) Low-Density Lipoprotein Metabolism in Mice with Soft Tissue Tumours,Biochim. Biophys. Acta 795(3), 589–595.
Lombardi, P., Norata, G., Maggi, F.M., Canti, G., Franco, P., Nicolin, A., and Catapano, A.L. (1989) Assimilation of LDL by Experimental Tumours in Mice,Biochim. Biophys. Acta 1003(3), 301–306.
Ho, Y.K., Smith, R.G., Brown, M.S., and Goldstein, J.L. (1978) Low-Density Lipoprotein (LDL) Receptor Activity in Human Acute Myelogenous Leukemia Cells,Blood 52(6), 1099–1114.
Gal, D., MacDonald, P.C., Porter, J.C., and Simpson, E.R. (1981) Cholesterol Metabolism in Cancer Cells in Monolayer Culture III. Low-Density Lipoprotein Metabolism,Int. J. Cancer 28(3), 315–319.
Vitols, S., Gahrton, G., Ost, A., and Peterson, C.O. (1984) Elevated Low Density Lipoprotein Receptor Activity in Leukemic Cells with Monocytic Differentiation,Blood 63(5), 1186–1193.
Vitols, S., Gahrton, G., Bjorkholm, M., and Peterson, C. (1985) Hypocholesterolaemia in Malignancy Due to Elevated Low-Density-Lipoprotein-Receptor Activity in Tumour Cells: Evidence from Studies in Patients with LeukaemiaLancet 2(8645):1150–1154.
Rudling, M.J., Angelin, B., Peterson, C.O., and Collins, V.P. (1990) Low Density Lipoprotein Receptor Activity in Human Intracranial Tumors and Its Relation to the Cholesterol Requirement,Cancer Res. 50(3):483–487.
Rodwell, V.W., Nordstrom, J.L., and Mitschelen, J.J. (1979) Regulation of HMG-CoA reductase,Adv. Lipid Res. 14:1–74.
Goldstein, J.L., and Brown, M.S. (1990) Regulation of the Mevalonate Pathway,Nature 343, 425–430.
Schmidt, R.A., Schneider, C.J., and Glomset, J.A. (1984) Evidence for Post-Translational Incorporation of a Product of Mevalonic Acid into Swiss 3T3 Cell Proteins,J. Biol. Chem. 259(16), 10175–10180.
Maltese, W.A. (1990) Post-Translational Modification of Proteins by Isoprenoids in Mammalian Cells,FASEB J. 4(15), 3319–3328.
Maltese, W.A. (1983) 3-Hydroxyl-3-Methylglutaryl Coenzyme A Reductase in Human Brain Tumors,Neurology 33(10), 1294–1299.
Engstrom, W., and Schofield, P.M. (1987) Expression of the 3-Hydroxy-3-Methylglutaryl Coenzyme A-Reductase and LDL-Receptor and LDL-Receptor Genes in Human Embryonic Tumours and in Normal Foetal Tissues,Anticancer Research 7(3 Pt B.), 337–342.
Bennis, F., Favre, G., Le Gaillard, F., and Soula, G. (1993) Importance of Mevalonate-Derived Products in the Control of HMG-CoA Reductase Activity and Growth of Human Lung Adenocarcinoma Cell Line A549,Int. J. Cancer 55(4), 640–645.
Goldstein, J.L., and Brown, M.S. (1977) The Low-Density Lipoprotein Patyway and Its Relation to Attherosclerosis,Ann. Rev. Biochem. 46, 897–930.
Endo, A. (1992) The Discovery and Development of HMG-CoA Reductase Inhibitors,J. Lipid Res. 33(11), 1569–1582.
Goldstein, J.L., Helgeson, J.A.S., and Brown, M.S. (1979) Inhibition of Cholesterol Synthesis with Compactin Renders Growth of Cultured Cells Dependent on the Low Density Lipoprotein Receptor,J. Biol. Chem. 254(12), 5403–5409.
Fabricant, M., and Broitman, S.A. (1990) Evidence for Deficiency of Low Density Lipoprotein Receptor on Human Colonic Carcinoma Cell Lines,Cancer Res. 50(3), 632–636.
Reimann, F.M., Herold, G., Schneider, A., and Stange, E.F. (1991) Compartmentalization of Cholesterol Metabolism and Cellular Growth in Cultured Intestinal Crypt Cells,Biochim. Biophys. Acta 1085(3), 315–321.
Fellermann, K., Reimann, F.M., Herold, G., and Stange, E.F. (1992) Mevinolin, A Competitive Inhibitor of Hydroxymethylglutaryl Coenzyme A Reductase, Suppresses Enterolcyte Esterification of Exogenous. But Not Endogenous Cholesterol,Biochim. Biophys. Acta 1165(1), 78–83.
Reimann, F.M., Herold, G., Grosshans, I., Rogler, G., Fellermann, K., and Stange, E.F. (1992) Regulation of Cholesterol Metabolism and Low-Density Lipoprotein Binding in Human Intestinal Caco-2 Cells,Digestion 51(1), 10–17.
Viallard, V., Castan, I., Trocheris, V., and Lacombe, C. (1992) Fate of Exogensous and Newly Synthesized Cholesterol in Intestinal Cell Lines,Int. J. Biochem. 24(8), 1315–1321.
Zweibaum, A., Pinto, M., Chevalier, G., Bussaulx, E., Triadoo, N., Enterocytic Differentiation of a Subpopulation of the Human Colon Tumor Cell Line HT-29 Selected for Growth in Sugar-Free Medium and Its Inhibition by Glucose,J. Cell Physiol. 122(1), 21–29.
Chantret, I., Barbat, A., Dussaulx, E., Brattain, M.G., and Zweibaum, A. (1988) Epithelial Polarity, Villin Expression and Enterocytic Differentiation of Cultured Human Colon Carcinoma Cells: A Survey of Twenty Cell Lines,Cancer Res. 48(7), 1936–1942.
Brown, M.S., Faust, J.R., and Goldstein, J.L. (1978) Induction of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Activity in Human Fibroblasts Incubated with Compactin (ML-236B), A Competitive Inhibitor of the Reductase,J. Biol. Chem. 253(4), 1121–1128.
Goldstein, J.L., Basu, S.K., and Brown, M.S. (1983) Receptor-Mediated Endocytosis of Low-Density Lipoprotein in Cultured Cells,Methods in Enzymol. 98, 241–260.
Wilkinson, J., and Broitmans, S. (1993) Effect of Low Density Lipoprotein (LDL) upon Proliferation in Three Human Adeno-carcinoma Cell Lines, inProceedings of the American Association for Cancer Research, Vol. 34, p. 55.
Brown, M.S., Dana, S.E., and Goldstein, J.L. (1975) Cholesterol Ester Formation in Cultured Human Fiborblasts. Stimulation by Oxygenated Sterols,J. Biol. Chem. 250(10): 4025–4027.
Goldstein, J.L., and Brown, M.S. (1974) Binding and Degradation of Low Density Lipoproteins by Cultured Human Fibroblasts. Comparison of Cells from A Normal Subject and from a Patient with Homozygous Familial Hypercholesterolemia,J. Biol. Chem. 249(16), 5153–5162.
Brown, M.S., Dana, S.E., and Goldstein, J.L. (1973) Regulation of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Activity in Human Fibroblasts by Lipoproteins,Proc. Natl. Acad. Sci. (USA) 70(7), 2162–2166.
Stange, E., and Dietschy, J.M. (1983) Cholesterol Synthesis and Low Density Lipoprotein Uptake Are Regulated Independently in Rat Small Intestinal Epithelium,Proc. Natl. Acad. Sci. (USA) 80(18), 5739–5743.
Safanova, I.G., Sviridov, D.D., Roytman, A., Rytikov, F.M., Dolgov, V.V., Nano, J.L., Rampal, P., and Repin, V.S. (1993) Cholesterol Uptake in the Human Intestine. Hypo- and Hyperresponsivenuess,Biochim. Biophys. Acta 1166(2–3), 313–316.
Suckling, K.E., and Stange, E.F. (1985) Role of Acyl-CoA: Cholesterol Acyltransferase in Cellular Cholesterol Metabolism,J. Lipid Res. 26, 647–671.
Viallard, V., Lacombe, C., Trocheris, V., Tabacik, C., and Aliau, S. (1990) Metabolism of Low-Density Lipoprotein in Differentiated and Undifferentiated HT29 Colon Cancer Cells,Int. J. Cancer 46(2), 320–325.
Nano, J.L., Barbaras, R., Negrel, R., and Rampal, P. (1976) Regulation of Cholesterol Synthesis and Binding of Lipoproteins in Cultured Rat Intestinal Epithelial Cells,Biochim. et Biophys. Acta 876(1), 72–789.
Viallard, V., Lacombe, C., Nebot, C., and Castan, I. (1991) Acyl-CoA: Cholesterol Acyltransferase in HT 29 Cell Subpopulations. Defect of Activity in the Undifferentiated Cells,Biochim. Biophys. Acta. 1085(2), 265–271.
Broitman, S.A. (1986) Dietary Cholesterol, Serum Cholesterol, and Colon Cancer: A Review,Advances in Experimental Medicine and Biology, (Poirier, L.A., Newberne, P.M., and Pariza, M.W., eds.) pp. 137–182, Plenum Press, New York.
Winawer, S.J., Flehinger, B.J., Buchalter, J., Herbert, E., and Shike, M. (1990) Declining Serum Cholesterol Levels Prior to Diagnosis of Colon Cancer. A Time-Trend, Case-Control Study,JAMA 263(15), 2083–2085.
Cowan, L.D., O'Connell, D.L., Criqui, M.H., Barrett-Connor, E., Bush, T.L., and Wallace, R.B. (1990) Cancer Mortality and Lipid and Lipoprotein Levels. Lipid Research Clinics Program Mortality Follow-up Study,Am. J. Epiodemiol. 131(3):468–482.
Kreger, B.E., Anderson, K.M., Schtazkin, A., and Splansky, G.L. (1992) Serum Cholesterol Level, Body Mass Index, and the Risk of Colon Cancer. The Framingham Study,Cancer 70(5), 1038–1043.
Sotnikov, A.V., Kupchik, H.Z., Gottlieb, L.S., Steele, G., and Broitman, S.A. (1992)Gastroenterology 102, A400.
Fong, L.G., Bonney, E., Kosek, J., and Cooper, A.D. (1989) Immunohistochemical Localization of Low Density Lipoprotein Receptors in Adrenal Gland, Liver, and Intestine,J. Clin. Invest. 84(3), 847–856.
Mazzone, T., Basheeruddin, K., Ping, L., and Schick, C. (1990) Relation of Growth- and Sterol-Related Regulatory Pathways for Low Density Lipoprotein Receptor Gene Expression,J. Biol. Chem. 265(9), 5145–5149.
Tavangar, K., and Kraemer, F.B. (1988) The Regulation of Hydroxymethylglutaryl-CoA Reductase in Cultured Cells,Biochim. Biophys. Acta 970(3), 251–261.
Caruso, M.G., Notarnicola, M., Cavallini, A., Guerra, V., Misciagna, G., and Di Leo, A. (1993) Demonstration of Low Density Lipoprotein Receptor in Human Colonic Carcinoma and Surrounding Mucosa by Immunoenzymatic Assay,Ital. J. Gastroenterol. 25(7), 361–367.
Stange, E.F., and Dietschy, J.M. (1983) Absolute Rates of Cholesterol Synthesis in Rat Intestinein vitro andin vivo: A Comparison of Different Substrates in Slices and Isolated Cells,J. Lipid Res. 24(1), 72–82.
Vlodavsky, I., Fielding, P.F., Fielding, C.J., and Gospodarowicz, D. (1978) Role of Contact Inhibition in the Regulation of Receptor-Mediated Uptake of Low Density Lipoprotein in Cultured Vascular Endothelial Cells,Proc. Natl. Acad. Sci. (USA) 75(1), 356–360.
Kruth, H.S., Avigan, J., Gamble, W., and Vaugham, M. (1979) Effect of Cell Density on Binding and Uptake of Low Density Lipoprotein by Human Fibroblasts,J. Cell. Biol. 83(3), 588–594.
Gal, D., MacDonald, P.C., Porter, J.C., Smith, J.W., and Simpson, E.R. (1981) Effect of Cell Density and Confluency on Cholesterol Metabolism in Cancer Cells in Monolayer Culture,Cancer Res. 41(2), 473–477.
Rotheneder, M., and Kostner, G.M. (1989) Effects of Low- and High-Density Lipoproteins on the Proliferation of Human Breast Cancer Cellsin vitro: Differeces Between Hormone-Dependent and Hormone-Independent Cell Lines,Int. J. Cancer 43(5), 875–879.
Villiard, V., Lacombe, C., Trocheris, V., Tabacik, C., and Aliau, S. (1990) Metabolism of Low- Density Lipoprotein in Differentiated and Uniifferentiated Ht 29 Colon Cancer Cells,Int. J. Cancer 46(2), 320–325.
Kenagy, R., Bierman, E.L., and Schwartz, A. (1983) Regulation of Low-Density Lipoprotein Metabolism by Cell Density and Proliferative State,J. Cell. Physiol. 116(3), 404–408.
Michelassi, F., Leuthner, S., Lubienski, M., Bostwick, D., Rodgers, J., and Handcock, M. (1987) Ras Oncogene p21 Levels Parallel Malignant Potential of Different Human Colonic Benign Conditions,Arch. Surg. 122(12), 1414–1416.
Hand, P.H., Thor, A., Wunderlich, D., Muraro, R., Caruso, A., and Schlom, J. (1984) Monoclonal Antibodies of Predefined Specificity Detect Activatedras Gene Expression in Human Mammary Carcinomas,Proc. Natl. Acad. Sci. 81, 5227–5231.
Hand, P.H., Thor, A., Wunderlich, D., Muraro, R., Caruso, A., and Schlom, J. (1984)Proc. Natl. Acad. Sci. (USA) 81, 5227–5231.
Bennis, F., Favre, G., Le Gaillard, F., and Soula, G. (1993) Importance of Mevalonate-Derived Products in the Control of HMG-CoA Reductase Activity and Growth of Human Lung Adenocarcinoma Cell Line A549,Int. J. Cancer 55(4), 640–645.
Maltese, W.A., Defendini, R., Green, R.A., Sheridan, K.M., and Donley, D.K. (1985) Suppression of Murine Neuroblastoma Growthin vivo by Mevinolin, A Competitive Inhibitor of 3-Hydroxy-3-Methylglutary-Coenzyme A Reductase,J. Clin. Invest. 75(5), 1748–1754.
Sumi, S.R., Beauchamp, R.D., Townsend, C.M., Uchida, T., Murakami, M., Rajaraman, S., Ishizuka, J., and Thompson, J.C. (1992) Inhibition of Pancreatic Adencarcinoma Cell Growth by Lovastatin,Gastroenterology 103(3), 982–989.
Author information
Authors and Affiliations
About this article
Cite this article
Cerda, S.R., Wilkinson, J. & Broitman, S.A. Regulation of cholesterol synthesis in four colonic adenocarcinoma cell lines. Lipids 30, 1083–1092 (1995). https://doi.org/10.1007/BF02536608
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02536608